BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32319322)

  • 1. Steroidal pyrazolines as a promising scaffold in drug discovery.
    Bansal R; Singh R
    Future Med Chem; 2020 May; 12(10):949-959. PubMed ID: 32319322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.
    Matiadis D; Sagnou M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazolines: a biological review.
    Marella A; Ali MR; Alam MT; Saha R; Tanwar O; Akhter M; Shaquiquzzaman M; Alam MM
    Mini Rev Med Chem; 2013 May; 13(6):921-31. PubMed ID: 23544604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
    Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
    Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities of pyrazoline derivatives--a recent development.
    Kumar S; Bawa S; Drabu S; Kumar R; Gupta H
    Recent Pat Antiinfect Drug Discov; 2009 Nov; 4(3):154-63. PubMed ID: 19545230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of steroidal derivatives containing substituted, fused and spiro pyrazolines.
    Romero-López A; Montiel-Smith S; Meza-Reyes S; Merino-Montiel P; Vega-Baez JL
    Steroids; 2014 Sep; 87():86-92. PubMed ID: 24928724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Pyrazolines as Biologically Active and Fluorescent Agents, An Overview.
    Singh P; Singh J; Pant GJ; Rawat MSM
    Anticancer Agents Med Chem; 2018; 18(10):1366-1385. PubMed ID: 29532762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents.
    Cai X; Zhao S; Cai D; Zheng J; Zhu Z; Wei D; Zheng Z; Zhu H; Chen Y
    Steroids; 2019 Jun; 146():70-78. PubMed ID: 30951758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalostatin analogues--synthesis and biological activity.
    Flessner T; Jautelat R; Scholz U; Winterfeldt E
    Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advancements in the development of bioactive pyrazoline derivatives.
    Nehra B; Rulhania S; Jaswal S; Kumar B; Singh G; Monga V
    Eur J Med Chem; 2020 Nov; 205():112666. PubMed ID: 32795767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents.
    Banday AH; Mir BP; Lone IH; Suri KA; Kumar HM
    Steroids; 2010 Dec; 75(12):805-9. PubMed ID: 20206644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
    Viveka S; Dinesha ; Shama P; Nagaraja GK; Ballav S; Kerkar S
    Eur J Med Chem; 2015 Aug; 101():442-51. PubMed ID: 26186150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eco-Friendly Synthesis, Characterization and Biological Evaluation of Some Novel Pyrazolines Containing Thiazole Moiety as Potential Anticancer and Antimicrobial Agents.
    Edrees MM; Melha SA; Saad AM; Kheder NA; Gomha SM; Muhammad ZA
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights on Steroidal Arylidene Derivatives as a Source of Pharmacologically Active Compounds: A Review.
    Brito V; Alves G; Almeida P; Silvestre S
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the therapeutic applications of pyrazolines.
    Shaaban MR; Mayhoub AS; Farag AM
    Expert Opin Ther Pat; 2012 Mar; 22(3):253-91. PubMed ID: 22397588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
    Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
    Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
    Abdellatif KRA; Bakr RB
    Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives.
    Dey P; Kundu A; Chakraborty HJ; Kar B; Choi WS; Lee BM; Bhakta T; Atanasov AG; Kim HS
    Int J Cancer; 2019 Oct; 145(7):1731-1744. PubMed ID: 30387881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazine as a promising scaffold for its versatile biological behavior.
    Singla P; Luxami V; Paul K
    Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.